Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2007 | 57 | 3 | 381-385
Tytuł artykułu

Monitoring obesity during dietary therapies using hypocaloric diet and vegetable soup supplement

Treść / Zawartość
Warianty tytułu
Języki publikacji
This study was aimed at determining the effects of a radish-root-based mixed dried vegetable soup supplement as an adjunct to a balanced hypocaloric diet therapy in the management of obesity. Sixteen healthy obese middle aged women, divided into two equal groups, followed a hypocaloric (1000 Kcal/day) diet for four weeks. The first group consumed an additional portion of the soup twice daily, i.e. before lunch and before dinner. The second group served as control. Relevant anthropometric and biochemical parameters were measured before, after two and after four weeks. Both, the soup and control dieters lost 4.18% and 4.71% of their weights, respectively. The soup dieters showed a significant decrease in blood pressure and triglycerides. Total cholesterol levels showed slight variations in both groups. LDL-Cholesterol was significantly decreased in the control dieters, whereas superoxide dismutase (SOD) was significantly increased in the soup, but not in the control dieters. The negligible increase in the c-reactive protein (CRP) in the soup dieters contrasted with the highly significant rise of the control. Calcium was decreased to subnormal concentrations in both groups, while copper, zinc and magnesium showed variable but beneficial increases. We emphasize during and post-diet monitoring of serum TG, CRP and calcium for a more efficient obesity control. Regular consumption of the soup by virtue of its antioxidant and anti-inflammatory properties will help to blunt and/or delay weight cycling and other complications of obesity.
Opis fizyczny
  • National Research Centre, Tahrir Street, Dokki-Cairo, 12311, Egypt
  • 1. AOAC. Association of Official Analytical Chemists. 1990. Official Methods of Analysis of the Official Analytical Chemists. 2 vols. 15th Ed. Washington, DC. 70, 668, 931, 933 and 937.
  • 2. Astrup A., Raben A., Buemann B., Toubro S., Fat metabolism in the predisposition to obesity. Ann. N. Y. Acad. Sci., 1997, 827, 417–430.
  • 3. Bronner F., Pansu D., Nutritional aspects of calcium absorption. J. Nutr., 1999, 129, 9–12.
  • 4. Colberg S.R., Simoneau J.A., Theate F.L., Kelley D.E., Skeletal muscle utilization of FFA in women with visceral obesity. J. Clin. Invest., 1995, 95, 1846–1853.
  • 5. Delgado M.C., Potassium in hypertension. Curr. Hypertens. Rep., 2004, 6, 31–35.
  • 6. Dukes J.A., Chemicals and their biological activities in Raphanus sativus L.(Brassicaceae)- radish. 2004, in: Phytochemicals and Ethnobotanical Databases (ed. J.A. Duke). USDA- ARS-NGRL, Beltsville Agricultural Research Center, Beltsville, Maryland EDT.
  • 7. Durnin J.V.G.A., Womersley J., Body fat assessed from total body density and its estimation from skin-fold thickness, measurements on 481 men and women from 16–72 years. Br. J. Nutr., 1974, 32, 77–97.
  • 8. Epstein L.H., Gordy C.C., Raynor H.A., Beddome M., Kilanowski C.K., Paluch R., Increasing fruit and vegetable intake and decreasing fat and sugar intake in families at risk for childhood obesity. Obes. Res., 2001, 9, 171–78.
  • 9. Francis G.A., Fayard E., Picard F., Auwerx J., Nuclear receptors and the control of metabolism. Ann. Rev. Physiol., 2002, 65, 261–311.
  • 10. Friedewald W.T., Levy R., Fredrickson D.S., Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem., 1972, 18, 499–502.
  • 11. Gartner C., Stahl W., Sies H., Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am. J. Clin. Nutr., 1997, 66, 116–122.
  • 12. Ghase G.W., Landen W.O., Soliman G.M., Methods modification for liquid chromatographic determination of thiamine, riboflavin and pyridoxine in medical foods. J. AOAC Intern., 1993,76, 1276–1280.
  • 13. Guesbeck N.R., Hickey M.S., MacDonald K.G., Pories W.J., Harper I., Ravussin E., Dohm G.L., Houmard J.A., Substrate utilization during exercise in formerly morbidly obese women. J. Appl. Physiol., 2001, 90, 1007–1012.
  • 14. Heilbronn L.K., Clifton P.M., C-reactive protein and coronary artery disease, influence of obesity, caloric restriction and weight loss. J. Nutr. Biochem., 2002, 13, 316–321.
  • 15. Hussein L., Bruggeman J., Zinc analysis of Egyptian food and estimated daily intakes among an urban population group. Food Chem., 1997, 58, 391–398.
  • 16. Jacobson T.A., “The lower the better” in hypercholesterolemia therapy, a reliable clinical guideline? Ann. Intern. Med., 2000, 133, 549–554.
  • 17. Jelliffe D.B., The assessment of the nutritional status of the community. World Health Organization. Geneva Monograph, 1966, pp. 53, 63–69.
  • 18. Keaney J.F. Jr., Larson M.G., Vasan R.S., Wilson P.W., Lipinska I., Corey D., Massaro J.M., Sutherland P., Vita J.A., Benjamin E.J., Obesity and systemic oxidative stress, Clinical correlates of oxidative stress in the Framingham study. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 434–439.
  • 19. Kelley D.E., Goodpaster B., Wing R.R., Simoneau J.A., Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am. J. Physiol. Endocrinol. Metab., 1999, 277, E1130–E1141.
  • 20. Kern P.A., Ranganathan S., Li C., Wood L., Ranaganthan G., Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab., 2001, 280, E745–E751.
  • 21. Kim J.K., Hickner R.C., Cortright R.L., Dohm G.L., Houmard J.A., Lipid oxidation is reduced in obese skeletal muscle. Am. J. Physiol., Endocrinol. Metab., 2000, 279, E1039–1044.
  • 22. Liu R.H., Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr., 2003, 78, 516S–520S.
  • 23. Lyon C.J., Law R.E., Hsueh, Minireview, adiposity, inflammation, and atherogenesis. Endocrinology, 2003, 144, 2195–2200.
  • 24. Martins I.J., Redgrave T.G., Obesity and post-prandial lipid metabolism. Feast or Famine? J. Nutr. Biochem., 2004, 15, 130–141.
  • 25. Müller M., Kersten S., Nutrogenomics, goals and strategies. Nature Rev./Genetics, 2003, 4, 315–322.
  • 26. Papanicolaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P., The pathophysiologic roles of interleukin-6 in human disease. Ann. Inter. Med., 1998, 128, 127–137.
  • 27. Rexrode K.M., Prodhan A., Manson J., Buring J.E., Ridker P.M., Relationship of total and abdominal adiposity with CRP and IL- 6 in women. Ann. Epidemiol., 2003, 13, 674–682.
  • 28. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R., Comparison of c-reactive protein and low- density lipoprotein levels in the prediction of first cardiovascular events. N. Engl. J. Med., 2002, 347, 1557–1565.
  • 29. Sanchez M.C., Jimenez E.A., Saura C.F., Study of low-density lipoprotein oxidizability indexes to measure the antioxidant activity of dietary polyphenols. Nutr. Res., 2000, 20, 941–53.
  • 30. Schutz Y., Abnormalities of fuel utilization as predisposing to the development of obesity in humans. Obes. Res., 1995, 3(Suppl. 2), 173S–178S.
  • 31. Seppo L., Jauhiainen T., Poussa T., Korpela R., A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr., 2003, 77, 326–330.
  • 32. Singleton V.L., Rossi J.A., Colorimetry of total phenolics with phosphomolybdic- phosphotungstic acid reagents. Am. J. Enol. Vitic., 1965, 16, 144–158.
  • 33. Tungtrongchitr R., PongPaew P., Phonrat B., Tungtrongchitr A., Viroonudomphol D., Vudhivai N., Schelp F.P., Serum copper, zinc, ceruloplasmin and superoxide dismutase in Thai overweight and obese. J. Med. Assoc. Thai., 2003, 86, 543–551.
  • 34. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B., Elevated c-reactive protein levels in overweight and obese adults. J. Am. Med. Assoc., 2000, 282, 2131–2135.
  • 35. Wee C.C., Hamel M.B., Davis R.B., Phillips R.S., Assessing the value of weight loss among primary care patients. J. Gen. Intern. Med., 2004, 19, 1206–1211.
  • 36. Zemel M., Dietary calcium and dairy products accelerate weight and fat loss during energy restriction in obese adults. Am. J. Clin. Nutr., 2003, 75, 342S–343S.
  • 37. Ziccardi P., Nappo F., Giugliano G., Esposito K., Marfella R., Cioffi M., Andrea F., Molinari A.M., Giugliano D., Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weigh loss over one year. Circulation, 2002, 105, 804–809.
  • 38. Zurlo F., Lillioja S., Esposito-Del Puente A., Nyomba B.L., Raz I., Saad M.F., Swinburn B.A., Knowler W.C., Bogardus C., Ravussin E., Low ratio of fat to carbohydrate oxidation as a predictor of weight gain, Study of 24-h RQ. Am. J. Physiol. Endorinol. Metab., 1990, 259, E650–E657.
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.